Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI

Background and Aims: Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. We investigated, in a highly translatable animal m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gemma Vilahur, Pablo Sutelman, Soumaya Ben-Aicha, Guiomar Mendieta, Monika Radiké, Leonie Schoch, Laura Casaní, María Borrell-Pagés, Teresa Padro, Lina Badimon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2022-05-01
Saila:Frontiers in Pharmacology
Gaiak:
spirulina
STEMI
cardioprotection
antioxidation
anti-inflammatory
anti-apoptotic
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fphar.2022.891801/full
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak